Loading
Empatica
Empatica Inc. is a medical technology and digital health company that focuses on AI-enabled wearable devices and software platforms for continuous health monitoring and neurological research. Founded in 2011 as a spinoff from the MIT Media Lab, Empatica is headquartered in Boston, Massachusetts, with additional offices in Milan, Italy, and Seoul, South Korea. The company specializes in developing FDA-cleared technologies for seizure monitoring and aims to provide real-time health insights through its innovative solutions. Empatica offers a range of services, including continuous health monitoring, remote patient monitoring, and clinical trial support. Their product lineup features medical-grade wearables like the EmbracePlus and Embrace2, which are designed for epilepsy monitoring and provide real-time alerts for caregivers. The company serves various customer segments, including patients, healthcare providers, research institutions, and pharmaceutical companies, delivering tools that enhance patient care and support clinical research. With a commitment to advancing health technology, Empatica is positioned as a leader in the HealthTech and Biotechnology sectors.
Funding
Every round, secondary, debt facility or acquisition involving Empatica that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$21M